Rationale and assessment of minimally invasive approaches to benign prostatic hyperplasia therapy.
Benign prostatic hyperplasia affects quality of life, with most patients complaining of symptoms related to urination. For this reason, successful treatments can be defined by (1) their effect on lower urinary tract symptoms, (2) their impact on quality of life, and (3) their ability to unobstruct the flow of urine through the prostate. Minimally invasive therapy (MIT), which includes transurethral microwave thermotherapy, water-induced thermotherapy, interstitial devices (eg, transurethral needle ablation), and interstitial laser treatments, offers physicians and their patients cost-effective alternatives for achieving a substantially improved quality of life at an acceptable level of risk. Evidence-based medicine indicates that MIT is safe and achieves significant symptomatic improvement. Compared with long-term medical management, minimally invasive procedures offer effective, well-tolerated 1-time intervention with lasting effects that can be achieved on an outpatient basis. This article reviews the options for MIT.
Larson
Thayne R
TR
Mayo Graduate School of Medicine, Scottsdale, Arizona, USA.
D000368:Aged; D000369:Aged, 80 and over; D005069:Evaluation Studies as Topic; D019317:Evidence-Based Medicine; D006801:Humans; D006979:Hyperthermia, Induced / Q000379:methods*; D008297:Male; D008872:Microwaves / Q000627:therapeutic use; D008875:Middle Aged; D019060:Minimally Invasive Surgical Procedures / Q000379:methods; D011470:Prostatic Hyperplasia / Q000628:therapy*; D011788:Quality of Life; D020728:Transurethral Resection of Prostate / Q000379:methods